This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Oliveira, L. M. B. Articles by Vallejo, M. Search for Related Content PubMed PubMed Citation Articles by Oliveira, L. M. B. Articles by Vallejo, M.

The Importance of Autosomal Genes in Kallmann Syndrome: Genotype-Phenotype Correlations and Neuroendocrine Characteristics¹

Reproductive Endocrine Sciences Center and National Center for Infertility Research (L.M.B.O., S.B.S., M.B., F.J.H., S.B.V., W.F.C., M.V.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114; Endocrine Unit (E.S.), Massachusetts General Hospital, Boston, Massachusetts 02114; and Unidade de Endocrinologia do Desenvolvimento (E.M.F.C., A.C.L.), Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, SP, Brazil

Address all correspondence and requests for reprints to: William F. Crowley, Jr., M.D., Reproductive Endocrine Unit, Massachusetts General Hospital BHX 511, 55 Fruit Street, Boston, Massachusetts 02114. E-mail: crowley.william{at}mgh.harvard.edu

Kallmann syndrome (KS) consists of congenital, isolated, idiopathic hypogonadotropic hypogonadism (IHH) and anosmia. The gene responsible for the X-linked form of KS, KAL, encodes a protein, anosmin, that plays a key role in the migration of GnRH neurons and olfactory nerves to the hypothalamus. In addition to X-linked pedigrees, autosomal dominant and recessive kindreds with KS have been reported. The relative importance of these autosomal vs. X-linked genes in producing KS, and the frequency of KAL mutations, are currently unknown because these are rare disorders and large series are unusual.

We examined 101 individuals with IHH (± anosmia) and their families to determine their modes of inheritance, incidence of mutations in the coding sequence of KAL, genotype-phenotype correlations, and [in a subset (n = 38)] their neuroendocrine phenotype.

Of the 101 patients, 59 had true KS (IHH + anosmia/hyposmia); whereas, in the remaining 42, no anosmia was evident in the patients or their families. Of the 59 KS patients, 21 were familial, whereas 38 were sporadic cases. Mutations in the coding sequence of KAL were identified in only 3 of 21 familial cases (14%) and 4 of 38 (11%) of the sporadic cases. Of the X-linked cases confirmed by mutational analysis, only 1 of 3 pedigrees appeared X-linked by inspection whereas the other 2 contained only affected brothers. Female members of known KAL mutation families (n = 3) exhibited no reproductive phenotype and were not anosmic, whereas families with anosmic women (n = 3) were not found to carry mutations in KAL. Mutations were uniformly absent in nonanosmic IHH probands (n = 42), as well as in families with both anosmic and nonanosmic members (n = 2). Overall, 4 novel mutations were identified (C172R, R191x, R457x, and delC@L600).

With respect to neuroendocrine phenotype, KS men with documented KAL mutations (n = 8) had completely apulsatile LH secretion, whereas those with autosomal modes of inheritance demonstrated a more variable spectrum with evidence of enfeebled (but present) GnRH-induced LH pulses.

Our conclusions are: 1) Confirmed mutations in the coding sequence of the KAL gene occur in the minority of KS cases, i.e. only 14% of familial and 11% of sporadic cases; 2) The majority of familial (and presumably sporadic) cases of KS are caused by defects in at least two autosomal genes that are currently unknown; 3) Obligate female carriers in families with KAL mutations have no discernible phenotype; 4) KAL mutations are uniformly absent in patients with either normosmic IHH or in families with both anosmic and nonanosmic individuals; and 5) Patients with KAL mutations have apulsatile LH secretion consistent with a complete absence of GnRH migration of GnRH cells into the hypothalamus, whereas evidence of present (but enfeebled) GnRH-induced LH pulses may be present in autosomal KS cases. Taken together, these findings suggest that autosomal genes account for the majority of familial cases of KS, and that unique neuroendocrine phenotypes consistent with some GnRH neuronal migration may exist in these patients.

This article has been cited by other articles:

				P. Canto, P. Munguia, D. Soderlund, J. J. Castro, and J. P. Mendez Genetic Analysis in Patients With Kallmann Syndrome: Coexistence of Mutations in Prokineticin Receptor 2 and KAL1 J Androl, January 1, 2009; 30(1): 41 - 45. [Abstract] [Full Text] [PDF]

				L. W. Cole, Y. Sidis, C. Zhang, R. Quinton, L. Plummer, D. Pignatelli, V. A. Hughes, A. A. Dwyer, T. Raivio, F. J. Hayes, et al. Mutations in Prokineticin 2 and Prokineticin receptor 2genes in Human Gonadotrophin-Releasing Hormone Deficiency: Molecular Genetics and Clinical Spectrum J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3551 - 3559. [Abstract] [Full Text] [PDF]

				S. Salenave, P. Chanson, H. Bry, M. Pugeat, S. Cabrol, J. C. Carel, A. Murat, P. Lecomte, S. Brailly, J.-P. Hardelin, et al. Kallmann's Syndrome: A Comparison of the Reproductive Phenotypes in Men Carrying KAL1 and FGFR1/KAL2 Mutations J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 758 - 763. [Abstract] [Full Text] [PDF]

				T. Raivio, J. Falardeau, A. Dwyer, R. Quinton, F. J. Hayes, V. A. Hughes, L. W. Cole, S. H. Pearce, H. Lee, P. Boepple, et al. Reversal of Idiopathic Hypogonadotropic Hypogonadism N. Engl. J. Med., August 30, 2007; 357(9): 863 - 873. [Abstract] [Full Text] [PDF]

				R. S. Ribeiro, T. C. Vieira, and J. Abucham Reversible Kallmann syndrome: report of the first case with a KAL1 mutation and literature review Eur. J. Endocrinol., March 1, 2007; 156(3): 285 - 290. [Abstract] [Full Text] [PDF]

				B. Bhagavath, N. Xu, M. Ozata, R. L. Rosenfield, D. P. Bick, R. J. Sherins, and L. C. Layman KAL1 mutations are not a common cause of idiopathic hypogonadotrophic hypogonadism in humans Mol. Hum. Reprod., March 1, 2007; 13(3): 165 - 170*. [Abstract] [Full Text] [PDF]

				F. Cerrato, J. Shagoury, M. Kralickova, A. Dwyer, J. Falardeau, M. Ozata, G. Van Vliet, P. Bouloux, J. E Hall, F. J Hayes, et al. Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S3 - S10. [Abstract] [Full Text] [PDF]

				E. B. Trarbach, E. M. F. Costa, B. Versiani, M. de Castro, M. T. M. Baptista, H. M. Garmes, B. B. de Mendonca, and A. C. Latronico Novel Fibroblast Growth Factor Receptor 1 Mutations in Patients with Congenital Hypogonadotropic Hypogonadism with and without Anosmia J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4006 - 4012. [Abstract] [Full Text] [PDF]

				G. A. Schwarting, T. R. Henion, J. D. Nugent, B. Caplan, and S. Tobet Stromal cell-derived factor-1 (chemokine C-X-C motif ligand 12) and chemokine C-X-C motif receptor 4 are required for migration of gonadotropin-releasing hormone neurons to the forebrain. J. Neurosci., June 21, 2006; 26(25): 6834 - 6840. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, and C. Y. Bowers Somatotropic and Gonadotropic Axes Linkages in Infancy, Childhood, and the Puberty-Adult Transition Endocr. Rev., April 1, 2006; 27(2): 101 - 140. [Abstract] [Full Text] [PDF]

				E. B Trarbach, M. T M Baptista, H. M Garmes, and C. Hackel Molecular analysis of KAL-1, GnRH-R, NELF and EBF2 genes in a series of Kallmann syndrome and normosmic hypogonadotropic hypogonadism patients J. Endocrinol., December 1, 2005; 187(3): 361 - 368. [Abstract] [Full Text] [PDF]

				H. Kim, S R Herrick, E Lemyre, S Kishikawa, J A Salisz, S Seminara, M E MacDonald, G A P Bruns, C C Morton, B J Quade, et al. Hypogonadotropic hypogonadism and cleft lip and palate caused by a balanced translocation producing haploinsufficiency for FGFR1 J. Med. Genet., August 1, 2005; 42(8): 666 - 672. [Full Text] [PDF]

				C. Chalouhi, P. Faulcon, C. Le Bihan, L. Hertz-Pannier, P. Bonfils, and V. Abadie Olfactory Evaluation in Children: Application to the CHARGE Syndrome Pediatrics, July 1, 2005; 116(1): e81 - e88. [Abstract] [Full Text] [PDF]

				M.-H. Gannage-Yared, C. Dode, I. Ghanem, E. Chouery, N. Jalkh, J.-P. Hardelin, and A. Megarbane Coexistence of Kallmann syndrome and complete androgen insensitivity in the same patient Eur. J. Endocrinol., June 1, 2005; 152(6): 813 - 817. [Abstract] [Full Text] [PDF]

				N. Pitteloud, J. S. Acierno Jr., A. U. Meysing, A. A. Dwyer, F. J. Hayes, and W. F. Crowley Jr. Reversible Kallmann Syndrome, Delayed Puberty, and Isolated Anosmia Occurring in a Single Family with a Mutation in the Fibroblast Growth Factor Receptor 1 Gene J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1317 - 1322. [Abstract] [Full Text] [PDF]

				D. Gonzalez-Martinez, S.-H. Kim, Y. Hu, S. Guimond, J. Schofield, P. Winyard, G. B. Vannelli, J. Turnbull, and P.-M. Bouloux Anosmin-1 Modulates Fibroblast Growth Factor Receptor 1 Signaling in Human Gonadotropin-Releasing Hormone Olfactory Neuroblasts through a Heparan Sulfate-Dependent Mechanism J. Neurosci., November 17, 2004; 24(46): 10384 - 10392. [Abstract] [Full Text] [PDF]

				A. Cariboni, F. Pimpinelli, S. Colamarino, R. Zaninetti, M. Piccolella, C. Rumio, F. Piva, E. I. Rugarli, and R. Maggi The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons Hum. Mol. Genet., November 15, 2004; 13(22): 2781 - 2791. [Abstract] [Full Text] [PDF]

				N. Sato, N. Katsumata, M. Kagami, T. Hasegawa, N. Hori, S. Kawakita, S. Minowada, A. Shimotsuka, Y. Shishiba, M. Yokozawa, et al. Clinical Assessment and Mutation Analysis of Kallmann Syndrome 1 (KAL1) and Fibroblast Growth Factor Receptor 1 (FGFR1, or KAL2) in Five Families and 18 Sporadic Patients J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1079 - 1088. [Abstract] [Full Text] [PDF]

				R. G. Romanelli, T. Barni, M. Maggi, M. Luconi, P. Failli, A. Pezzatini, E. Pelo, F. Torricelli, C. Crescioli, P. Ferruzzi, et al. Expression and Function of Gonadotropin-releasing Hormone (GnRH) Receptor in Human Olfactory GnRH-secreting Neurons: AN AUTOCRINE GnRH LOOP UNDERLIES NEURONAL MIGRATION J. Biol. Chem., January 2, 2004; 279(1): 117 - 126. [Abstract] [Full Text] [PDF]

				N. Massin, C. Pecheux, C. Eloit, J.-L. Bensimon, J. Galey, F. Kuttenn, J.-P. Hardelin, C. Dode, and P. Touraine X Chromosome-Linked Kallmann Syndrome: Clinical Heterogeneity in Three Siblings Carrying an Intragenic Deletion of the KAL-1 Gene J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2003 - 2008. [Abstract] [Full Text] [PDF]

				J. C. Achermann, G. Ozisik, J. J. Meeks, and J. L. Jameson Genetic Causes of Human Reproductive Disease J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2447 - 2454. [Full Text] [PDF]

				D. Soderlund, P. Canto, and J. P. Mendez Identification of Three Novel Mutations in the KAL1 Gene in Patients with Kallmann Syndrome J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2589 - 2592. [Abstract] [Full Text] [PDF]

				N. Pitteloud, F. J. Hayes, P. A. Boepple, S. DeCruz, S. B. Seminara, D. T. MacLaughlin, and W. F. Crowley Jr. The Role of Prior Pubertal Development, Biochemical Markers of Testicular Maturation, and Genetics in Elucidating the Phenotypic Heterogeneity of Idiopathic Hypogonadotropic Hypogonadism J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 152 - 160. [Abstract] [Full Text] [PDF]